HDAC2 and osteosarcoma: Moreover, in a recent paper, for the first time, HDAC2 was highlighted as a key factor regulating in vivo cancer growth and cancer stem cells (CSCs) phenotype involved in cancer initiation, progression and chemoresistance of osteosarcoma (34).